BTRC and cholangiocarcinoma: Our results indicated that FBXW1 was more expressed in colon adenocarcinoma (COAD), cholangiocarcinoma (CHOL), lung adenocarcinoma (LUAD), liver hepatocellular carcinoma (LIHC), Prostate adenocarcinoma (PRAD), and stomach adenocarcinoma (STAD).